Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast (now on Twitter!), where we unpack the numbers behind the headlines.
The whole crew was back, with Natasha Mascarenhas and Danny Crichton and myself chattering with Chris Gates behind the scenes making it all work. An extra shoutout to Natasha this week as we spent a lot of time talking about edtech, a category that she spearheads for us and has brought to the show. It’s a big deal!
We’re on YouTube now, don’t forget, and with that, let’s get into the news:
- Climax Foods raised $7.5 million to help fuel its work to develop alt-foods that are not animal-based. The Equity crew votes that this is a tasty deal. And, Capchase has raised $4.6 million to help cash-out SaaS contracts ahead of their real revenue accrual. Our read is that more financing options for SaaS companies will lead to lower costs of capital for those startups that want it. And, the Envision Accelerator made it through batch one and is on to batch two.
- Then we chatted about edtech, with Natasha talking us through Owl Ventures raising huge new funds, Course Hero extending its Series B, Juni hitting $10M ARR and raising about as much, and Unacademy raising tons of cash from Vision Fund 2.
- Next up, Patreon also got a new check, which means that it eventually has to go public at some point given that it is now a fancy unicorn.
- And speaking of IPOs, Bumble is thinking about going public in 2021, Wish has filed, albeit privately, and GoodRX is going public as well. And it makes money.
- What else? This a16z post on IPOs that we fangirl/fanboy’d over as it is good. And we forgot to mention this Fred Wilson post, but it is also good.
And with that, we are nearly at the weekend which is a long one thanks to a holiday, so expect Equity Monday to be, in fact, Equity Tuesday next week. Hugs and good vibes from the Equity Crew!
Equity drops every Monday at 7:00 a.m. PT and Thursday afternoon as fast as we can get it out, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts.